Q3 2013
Released Nov 13, 2013, during market hours
10-Q filed Nov 13, 2013, 44 days after period end · 0001144204-13-060976
Q3 2013 · 10-Q
Revenue$5.95M$5.95M +9.9% vs Q3 2012+206.8% vs Q2 2013
Net Income$1.24M$1.24M +15.2% vs Q3 2012N/M vs Q2 2013
EPS Diluted$0.08$0.08 +14.3% vs Q3 2012N/M vs Q2 2013
Gross Profit$3,817,000+12.3%
Operating Income$1,239,000+15.5%
Operating Cash Flowderived-$3,260,000N/M
Free Cash Flowderived-$3,334,000N/M
Margins · derived
Gross margin64.2%+1.4 pt vs Q3 2012
Operating margin20.8%+1.0 pt vs Q3 2012
Net margin20.8%+1.0 pt vs Q3 2012
What the release said
No earnings release is on file for this quarter. Its figures came with the 10-Q.
Same quarter
| Metric | Q3 2013 | Q3 2012 | Q3 2011 | Q3 2010 |
|---|---|---|---|---|
| Revenue | $5.95M | $5.42M | $5.08M | $5.20M |
| Net Income | $1.24M | $1.07M | $1.11M | $947.00K |
| EPS Diluted | $0.08 | $0.07 | $0.07 | $0.06 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
ProPhase Labs, Inc. · CIK 868278 · Engraved from SEC EDGAR